Cargando…

BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children

Currently available mRNA vaccines are extremely safe and effective to prevent severe SARS-CoV-2 infections. However, the emergence of variants of concerns (VOCs) has highlighted the importance of high population-based vaccine rates to effectively suppress viral transmission and breakthrough infectio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartsch, Yannic C., Chen, Jessica W., Kang, Jaewon, Burns, Madeleine D., St Denis, Kerri J., Sheehan, Maegan L., Davis, Jameson P., Edlow, Andrea G., Balazs, Alejandro B., Yonker, Lael M., Alter, Galit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719544/ https://www.ncbi.nlm.nih.gov/pubmed/36463314 http://dx.doi.org/10.1038/s41541-022-00575-w

Ejemplares similares

Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children
por: Burns, Madeleine D., et al.
Publicado: (2022)

SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children
por: Bartsch, Yannic C, et al.
Publicado: (2022)

Durability and cross-reactivity of SARS-CoV-2 mRNA vaccine in adolescent children
por: Burns, Madeleine D, et al.
Publicado: (2022)

Long-term humoral signatures following acute pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children
por: Burns, Madeleine D., et al.
Publicado: (2023)

Comprehensive antibody profiling of mRNA vaccination in children
por: Bartsch, Yannic C, et al.
Publicado: (2022)

Relationship between Anti-Spike Antibodies and Risk of SARS-CoV-2 Infection in Infants Born to COVID-19 Vaccinated Mothers
por: Burns, Madeleine D., et al.
Publicado: (2022)

Preserved recognition of Omicron spike following COVID-19 messenger RNA vaccination in pregnancy
por: Bartsch, Yannic C., et al.
Publicado: (2022)

COVID-19 booster dose induces robust antibody response in pregnant, lactating, and nonpregnant women
por: Atyeo, Caroline, et al.
Publicado: (2023)

Significantly elevated antibody levels and neutralization titers in nursing home residents after SARS-CoV-2 BNT162b2 mRNA booster vaccination
por: Canaday, David H., et al.
Publicado: (2021)

Neutrophil Profiles of Pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children
por: Boribong, Brittany P., et al.
Publicado: (2021)

Neutrophil profiles of pediatric COVID-19 and multisystem inflammatory syndrome in children
por: Boribong, Brittany P., et al.
Publicado: (2022)

Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residents
por: Canaday, David H., et al.
Publicado: (2021)

Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms
por: Atyeo, Caroline G., et al.
Publicado: (2022)

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
por: Reiter, Rieke, et al.
Publicado: (2022)

Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactions
por: Bartsch, Yannic C., et al.
Publicado: (2023)

Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine
por: Patalon, Tal, et al.
Publicado: (2022)

Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profiles
por: Kaplonek, Paulina, et al.
Publicado: (2021)

mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions
por: Kaplonek, Paulina, et al.
Publicado: (2022)

Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines
por: Naranbhai, Vivek, et al.
Publicado: (2021)

Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Naive Nursing Home Residents
por: Canaday, David H, et al.
Publicado: (2021)

Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccination
por: Nziza, Nadège, et al.
Publicado: (2023)

Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination
por: Grupel, Daniel, et al.
Publicado: (2021)

Longitudinal Analysis of SARS-CoV-2-Specific Cellular and Humoral Immune Responses and Breakthrough Infection following BNT162b2/BNT162b2/BNT162b2 and ChAdOx1/ChAdOx1/BNT162b2 Vaccination: A Prospective Cohort in Naive Healthcare Workers
por: Ko, Geon Young, et al.
Publicado: (2023)

Neutralizing Activity of BNT162b2-Elicited Serum
por: Liu, Yang, et al.
Publicado: (2021)

BNT162b2 vaccine for prevention of COVID-19
Publicado: (2021)

Boosting BNT162b2 vaccine efficacy in CLL
por: Bhat, Seema A., et al.
Publicado: (2022)

Erythema Multiforme after BNT162b2 Vaccination
por: Katayama, Sho, et al.
Publicado: (2022)

Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination
por: Lim, Xin Rong, et al.
Publicado: (2021)

Dynamics of Serum-Neutralizing Antibody Responses in Vaccinees through Multiple Doses of the BNT162b2 Vaccine
por: Sheehan, Jared, et al.
Publicado: (2023)

BNT162b2 mRNA vaccine elicited antibody response in blood and milk of breastfeeding women
por: Rosenberg-Friedman, Michal, et al.
Publicado: (2021)

Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses
por: Yonker, Lael M., et al.
Publicado: (2020)

Pfizer SARS-CoV-2 BNT162b2 mRNA vaccination (BNT162b2) has no adverse effect on elective oocyte cryopreservation outcomes
por: Karavani, Gilad, et al.
Publicado: (2022)

Immune Responses After Vaccination With Primary 2-Dose ChAdOx1 Plus a Booster of BNT162b2 or Vaccination With Primary 2-Dose BNT162b2 Plus a Booster of BNT162b2 and the Occurrence of Omicron Breakthrough Infection
por: Choi, Seong-Ho, et al.
Publicado: (2023)

Waning Immunity after the BNT162b2 Vaccine in Israel
por: Goldberg, Yair, et al.
Publicado: (2021)

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
por: Mevorach, Dror, et al.
Publicado: (2022)

Acute interstitial nephritis after vaccination with BNT162b2
por: Rieckmann, Sonja, et al.
Publicado: (2022)

Effectiveness of BNT162b2 against COVID-19 in adolescents
por: Powell, Annabel A, et al.
Publicado: (2022)

Acute myocarditis following administration of BNT162b2 vaccine
por: Habib, Mhd Baraa, et al.
Publicado: (2021)

Beyond neutralization for BNT162b2 mRNA vaccination
por: Damani-Yokota, Payal, et al.
Publicado: (2021)

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
por: Witberg, Guy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_me7mafgnqofe8ffaasdocolg1t